DENTSPLY SIRONA Inc

XRAY remains in a Stage 2 advance with a dominant Lockout Rally driving forced short covering and reclaiming key EMAs and the 200 DMA. Despite extreme overbought RSI and stretched valuation metrics, the active Lockout Rally override permits immediate participation. Medium- and short-term biases align bullish, warranting a Buy Now execution on breakout above recent multi-month highs.

• ↑Q1 revenue $880M vs. $842M consensus; 2026 guidance at $3.5–3.6B
• ↑R&D spend increasing under Return to Growth plan to drive new products
• ↓Adjusted EBITDA margin fell 430bps YoY amid volume and mix challenges